Today's News | Note: News feeds may no longer be available for the articles on this page.

India's Biocon in pact with Mylan for biologic drugs 6:53 AM 6/29/2009
Reuters - USA
Indian biotechnology firm Biocon Ltd said it has signed a definitive agreement with Mylan Inc to develop, manufacture, and supply generic biologic drugs globally. ...

Biotech: Generics Win a Round 4:33 AM 6/29/2009
BusinessWeek - USA
The end of market exclusivity does not mean that the innovator makes critical data available to generic companies as this article would suggest. ...

New Cancer Treatment Shows Promise 3:58 PM 6/28/2009
New York Times - United States
The EnGeneIC method uses minicells generated from mutant bacteria which can be loaded with chemicals and coated with antibodies that direct them toward tumor cells. ...

Sanofi Drug Cancer Risk Should Be Studied, Group Says 10:42 AM 6/27/2009
Bloomberg - USA
Sanofi-Aventis SA’s Lantus diabetes drug gets linked to an increased risk of cancer in studies in Germany and Sweden. Sanofi stands behind the safety of Lantus claiming the research wasn’t conclusive. ...

Takeda fails to get US approval for diabetes drug 5:01 AM 6/27/2009
Reuters - USA
Takeda Pharmaceutical's key diabetes drug failed to get US approval. The FDA wants more safety data. ...

FDA panel backs Ista drug for eye allergies 3:41 AM 6/27/2009
The Associated Press
FDA advisory panel finds that the anti-itching drug Bepreve from eye care company Ista Pharmaceuticals is safe and effective. ...

Smell-Loss Drug Escaped FDA Review Under Homeopathic Label 8:27 PM 6/26/2009
Bloomberg - USA
Matrixx International Inc was allowed to market homeopathic Zicam for a decade without a review for safety or effectiveness. Over 900 people lose sense of smell. Common sense was already missing. ...

Roche Pulling Acne Drug Accutane Off Market After Jury Verdicts 5:27 PM 6/26/2009
Bloomberg - USA
Roche Holding AG is pulling its Accutane acne medicine from the US market after juries awarded at least $33 million in damages to users with bowel disease. ...

Sun Pharma Awaits Clarity on FDA Move, Shares Slide 3:38 PM 6/26/2009
Wall Street Journal - USA
Sun Pharmaceutical Industries is waiting for more clarity on the US FDA's seizure of over 30 drugs made by the company's US unit Caraco Pharmaceutical Laboratories Ltd. ...

Irish court invalidates patent on Glaxo's top drug 2:26 PM 6/26/2009
Reuters - USA
A key patent protecting GlaxoSmithKline's top-selling drug was found invalid. Teva Pharmaceutical Industries' Ivax unit challenged the combination patent for Seretide (Advair in the US) relating to the combination of the active ingredients salmeterol and fluticasone propionate expiring in 2013. ...

Inotek Pharmaceuticals Reports Positive Glaucoma Study Results 12:04 PM 6/26/2009
Pharmaceutical Business Review - USA
Inotek reported positive results from phase I/II clinical trial of INO-8875 in patients with glaucoma. ...

UCB arthritis drug Cimzia wins EU watchdog approval 12:01 PM 6/26/2009
Reuters - USA
EU recommends approval of UCB SA's Cimzia drug as a treatment for rheumatoid arthritis. ...

Expect FDA Approval of AMAG Pharmaceutical's Feraheme 10:28 AM 6/26/2009
Seeking Alpha - New York,NY,USA
The US FDA is about to decide on the marketing application of AMAG Pharmaceuticals' Feraheme (ferumoxytol) for the treatment of iron deficiency in anemia patients with chronic kidney disease (CKD). ...

Conatus Pharmaceuticals Initiates Second Phase-II Hepatitis Trial 8:49 AM 6/26/2009
Pharmaceutical Business Review - USA
Conatus Pharmaceuticals initiated the second phase-II clinical trial with drug candidate CTS-1027 for the treatment of liver disease associated with Hepatitis C Virus (HCV) infection. ...

FDA Seeks More Data On Lundbeck's Serdolect Drug 4:34 AM 6/26/2009
Wall Street Journal - USA
H. Lundbeck said the US FDA requested more data on its Serdolect treatment for schizphrenia. ...

<- Day Earlier | Today's News